ASAH1 and intrahepatic cholangiocarcinoma: Our previous data showed that rolipram, a cAMP‐specific phosphodiesterase, increased pacemaking potential frequency, whereas SQ22536, an AC inhibitor, decreased pacemaking potential frequency in colonic ICCs but not in small intestinal ICC.